Bausch Health Companies (TSE:BHC) Stock Price Up 0.9% – What’s Next?

Shares of Bausch Health Companies Inc. (TSE:BHC) traded up 0.9% during trading on Thursday . The stock traded as high as C$8.97 and last traded at C$8.91. 218,073 shares were traded during mid-day trading, a decline of 40% from the average session volume of 361,495 shares. The stock had previously closed at C$8.83.

Bausch Health Companies Stock Performance

The company’s fifty day moving average price is C$7.63 and its 200 day moving average price is C$8.75. The company has a market cap of C$2.32 billion, a PE ratio of -13.04, a P/E/G ratio of 0.21 and a beta of 0.77. The company has a debt-to-equity ratio of -1,831.94, a current ratio of 1.19 and a quick ratio of 0.58.

Insider Transactions at Bausch Health Companies

In related news, Director John Paulson acquired 1,782,030 shares of the firm’s stock in a transaction that occurred on Friday, June 13th. The stock was acquired at an average price of C$8.14 per share, for a total transaction of C$14,501,803.73. Insiders have bought a total of 3,553,401 shares of company stock worth $27,087,675 in the last three months. Company insiders own 11.28% of the company’s stock.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.